First human test of eczema pill halted early
NCT ID NCT05288543
Summary
This was an early-stage study to check the safety of a new oral medication called IPG7236, intended for atopic dermatitis (eczema). It tested single and multiple doses in 63 healthy adults to see how the body processes the drug and if food affects it. The trial was terminated, meaning it was stopped before completion.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Scientia Clinical Research Ltd
Randwick, New South Wales, 2031, Australia
Conditions
Explore the condition pages connected to this study.